A. Misino

1.5k total citations · 1 hit paper
25 papers, 983 citations indexed

About

A. Misino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Misino has authored 25 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in A. Misino's work include Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Treatment and Pharmacology (5 papers). A. Misino is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Treatment and Pharmacology (5 papers). A. Misino collaborates with scholars based in Italy and United States. A. Misino's co-authors include Nicola Borsellino, Vittorio Gebbia, Evaristo Maiello, Massimo Lopez, Francesco Giuliani, Luigi Manzione, Giuseppe Colucci, Giacomo Cartenì, Nicola Gebbia and S. Romito and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Treatment Reviews.

In The Last Decade

A. Misino

25 papers receiving 949 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2005 586 citations Giuseppe Colucci, Vittorio Gebbia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Misino Italy	11	755	368	221	134	134	25	983
Seta Shahin United States	8	812 1.1×	319 0.9×	186 0.8×	127 0.9×	120 0.9×	13	948
B. Mirtsching United States	12	1.1k 1.5×	459 1.2×	131 0.6×	288 2.1×	182 1.4×	27	1.3k
S. Palmeri Italy	17	584 0.8×	228 0.6×	91 0.4×	116 0.9×	121 0.9×	78	821
Werner Freier Germany	15	513 0.7×	360 1.0×	143 0.6×	129 1.0×	186 1.4×	28	760
Kian Fong Foo Singapore	13	320 0.4×	238 0.6×	129 0.6×	74 0.6×	141 1.1×	24	712
Isabel Chirivella Spain	16	1.1k 1.5×	453 1.2×	258 1.2×	254 1.9×	246 1.8×	53	1.5k
E.U. Steinhauer Germany	6	860 1.1×	370 1.0×	196 0.9×	74 0.6×	116 0.9×	10	982
Thierry Guillot France	11	872 1.2×	338 0.9×	178 0.8×	48 0.4×	110 0.8×	21	1.1k
Nicola Borsellino Italy	10	707 0.9×	330 0.9×	226 1.0×	81 0.6×	101 0.8×	19	880
Scot Dowden Canada	14	624 0.8×	285 0.8×	124 0.6×	177 1.3×	81 0.6×	24	826

Countries citing papers authored by A. Misino

Since Specialization

Citations

This map shows the geographic impact of A. Misino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Misino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Misino more than expected).

Fields of papers citing papers by A. Misino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Misino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Misino. The network helps show where A. Misino may publish in the future.

Co-authorship network of co-authors of A. Misino

This figure shows the co-authorship network connecting the top 25 collaborators of A. Misino. A scholar is included among the top collaborators of A. Misino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Misino. A. Misino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizzo, Alessandro, Antonio Cusmai, Silvana Acquafredda, et al.. (2022). Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis. Cancers. 14(6). 1404–1404. 82 indexed citations

Rizzo, Alessandro, Antonio Cusmai, Silvana Acquafredda, et al.. (2022). KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer. Future Oncology. 18(18). 2301–2309. 52 indexed citations

Celio, Luigi, Diego Cortinovis, Luigi Cavanna, et al.. (2020). 1815MO Two simplified dexamethasone (DEX)-sparing regimens with NEPA for the prevention of emesis caused by cisplatin (DDP): A phase III, controlled, non-inferiority trial. Annals of Oncology. 31. S1048–S1048. 1 indexed citations

Cormio, Claudia, D. Bafunno, Annamaria Catino, et al.. (2017). P3.05-004 Psycho-Social Function and Caregiver's Burden in Patients with Advanced Lung Cancer. Journal of Thoracic Oncology. 12(1). S1414–S1415. 2 indexed citations

Galetta, Domenico, et al.. (2017). P3.02c-085 Neutrophil/Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer: Correlation with Prognosis and Response to Anti-PD1 Therapy. Journal of Thoracic Oncology. 12(1). S1329–S1330. 2 indexed citations

Grossi, Francesco, Lucio Crinò, A. Misino, et al.. (2016). Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy. Annals of Oncology. 27. vi369–vi369. 5 indexed citations

Galetta, Domenico, Annamaria Catino, & A. Misino. (2016). Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target.. PubMed. 5(1). 143–4. 6 indexed citations

Catino, Annamaria, et al.. (2015). An interdisciplinary early simultaneous palliative approach in advanced lung cancer (a-LC): Preliminary data in outpatient setting experience.. Journal of Clinical Oncology. 33(29_suppl). 138–138. 1 indexed citations

Galetta, Domenico, et al.. (2015). Bladder and Gastric Metastases from Lung Adenocarcinoma Harboring Codon 13 KRAS Mutation: a Case Report with Unusual Clinical Outcome. Tumori Journal. 101(5). e138–e140. 2 indexed citations

10.

Galetta, Domenico, Saverio Cinieri, Salvatore Pisconti, et al.. (2014). Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial. Clinical Lung Cancer. 16(4). 262–273. 50 indexed citations

11.

Ammendola, Michele, et al.. (2010). Mast cells positive to Tryptase correlates with protease-activated receptor-2 expression and microvascular density in breast cancer patients. BMC Geriatrics. 10(S1). 1 indexed citations

12.

Guida, Michele, et al.. (2010). 31 HIGH ACTIVITY OF SEQUENTIAL COMBINATION OF LOW DOSE CHEMO-MODULATING TEMOZOLOMIDE (TMZ) + FOTEMUSTINE (FM) IN METASTATIC MELANOMA (MM). A FEASIBILITY STUDY. Cancer Treatment Reviews. 36. S104–S104. 1 indexed citations

13.

Zizzo, Nicola, Rosa Patruno, Francesco Alfredo Zito, et al.. (2009). Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model. Leukemia & lymphoma. 51(2). 291–296. 27 indexed citations

14.

Patruno, Rosa, Nicola Arpaia, Cosmo Damiano Gadaleta, et al.. (2008). VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. Journal of Cellular and Molecular Medicine. 13(3). 555–561. 47 indexed citations

15.

Giuliani, Francesco, S. Romito, Evaristo Maiello, et al.. (2008). Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM). European Journal of Cancer Supplements. 6(14). 107–112. 1 indexed citations

16.

Lorusso, Vito, Massimiliano Spada, A. Misino, et al.. (2006). Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). Annals of Oncology. 17. vii15–vii17. 27 indexed citations

17.

Lorusso, Vito, Massimiliano Spada, A. Misino, et al.. (2006). Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). Journal of Clinical Oncology. 24(18_suppl). 10673–10673. 12 indexed citations

18.

Palmeri, S., Stefano Spada, Gianfranco Filippelli, et al.. (2005). Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study. Oncology. 68(4-6). 438–445. 16 indexed citations

19.

Lorusso, Vito, E. Crucitta, Nicola Silvestris, et al.. (2003). A Phase I Study of Capecitabine in Combination with Vinorelbine in Advanced Breast Cancer. Clinical Breast Cancer. 4(2). 138–141. 20 indexed citations

20.

Latorre, Agnese, M. De Lena, Annamaria Catino, et al.. (2002). Epithelial ovarian cancer: Second and third line chemotherapy (Review). International Journal of Oncology. 21(1). 179–86. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact